Overview

An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

Status:
Withdrawn
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
NBI-34060 is an investigational (research) medication being studied in people with insomnia. The current study is designed to evaluate how people, who experience a nighttime awakening with difficulty returning to sleep, feel during the next day after dosing with NBI-34060. The study will also examine the pattern and extent of nighttime awakenings as reported by the patients, as well as and the patient's sleep experience during treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Neurocrine Biosciences
Treatments:
Indiplon